Steven Kay

Steven Kay currently serves as Lead Scientist at Sygnature Discovery, a position held since October 2019, having advanced through various roles including Senior Scientist and Scientist. Prior experience includes a Final Year Project at the University of Strathclyde focusing on the synthesis of small molecule probes for PIM kinases, as well as an industrial placement at Redx Pharma in oncology research. Steven Kay holds a PhD in Medicinal Chemistry and a Master's Degree in Chemistry with Drug Discovery, both from the University of Strathclyde, where education was completed between 2010 and 2019.